Masters WH, Johnson VE. Human sexual response. Little, Brown and Company: Boston, MA; 1966.
Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003;44(6):637–49.
Giuliano F, Clement P. Physiology of ejaculation: emphasis on serotonergic control. Eur Urol. 2005;48(3):408–17.
Newman HF, Reiss H, Northup JD. Physical basis of emission, ejaculation, and orgasm in the male. Urology. 1982;19(4):341–50.
Barnas JL, Pierpaoli S, Ladd P, Valenzuela R, Aviv N, Parker M, et al. The prevalence and nature of orgasmic dysfunction after radical prostatectomy. BJU Int. 2004;94(4):603–5.
Schlegel PN, Walsh PC. Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function. J Urol. 1987;138(6):1402–6.
Keast J. Autonomic Ganglia. In: McLachlan E, editor. Pelvic ganglia. Luxemburg: Harwood Academin; 1995. p. 445–79.
Ver Voort SM. Ejaculatory stimulation in spinal-cord injured men. Urology. 1987;29(3):282–9.
Amelar RD, Hotchkiss RS. The split ejaculate: its use in the management of male infertility. Fertil Steril. 1965;16:46–60.
McKenna KE, Chung SK, McVary KT. A model for the study of sexual function in anesthetized male and female rats. Am J Physiol. 1991;261(5 Pt 2):R1276–85.
Truitt WA, Coolen LM. Identification of a potential ejaculation generator in the spinal cord. Science. 2002;297(5586):1566–9.
Allard J, Truitt WA, McKenna KE, Coolen LM. Spinal cord control of ejaculation. World J Urol. 2005;23(2):119–26.
Coolen LM, Allard J, Truitt WA, McKenna KE. Central regulation of ejaculation. Physiol Behav. 2004;83(2):203–15.
Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281(6):537–44.
Dunn KM, Croft PR, Hackett GI. Association of sexual problems with social, psychological, and physical problems in men and women: a cross sectional population survey. J Epidemiol Community Health. 1999;53(3):144–8.
Masters WH, Johnson VE. Human sexual inadequacy. London: Churchill; 1970. p. xi–467.
Waldinger MD, Schweitzer DH. Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part I – validity of DSM-IV-TR. J Sex Med. 2006;3(4):682–92.
Symonds T, Perelman M, Althof S, Giuliano F, Martin M, Abraham L, et al. Further evidence of the reliability and validity of the premature ejaculation diagnostic tool. Int J Impot Res. 2007;19(5):521–5.
Waldinger MD, Hengeveld MW, Zwinderman AH. Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry. 1994;151(9):1377–9.
Patrick DL, Althof SE, Pryor JL, Rosen R, Rowland DL, Ho KF, et al. Premature ejaculation: an observational study of men and their partners. J Sex Med. 2005;2(3):358–67.
Rowland DL, Cooper SE, Schneider M. Defining premature ejaculation for experimental and clinical investigations. Arch Sex Behav. 2001;30(3):235–53.
Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH. Proposal for a definition of lifelong premature ejaculation based on epidemiological stopwatch data. J Sex Med. 2005;2(4):498–507.
Dinsmore WW, Ralph DJ, Kell P, Wylie KR, Dean JP, Novak C, et al. Evaluation of the sexual assessment monitor, a diagnostic device used to electronically quantify ejaculatory latency time: findings from three studies. BJU Int. 2006;98(3):613–8.
Lue TF, Giuliano F, Montorsi F, Rosen RC, Andersson KE, Althof S, et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2004;1(1):6–23.
Sharlip ID. Guidelines for the diagnosis and management of premature ejaculation. J Sex Med. 2006;3 Suppl 4:309–17.
Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, et al. AUA guideline on the pharmacologic management of premature ejaculation. J Urol. 2004;172(1):290–4.
Colpi GM, Fanciullacci F, Beretta G, Negri L, Zanollo A. Evoked sacral potentials in subjects with true premature ejaculation. Andrologia. 1986;18(6):583–6.
Fanciullacci F, Colpi GM, Beretta G, Zanollo A. Cortical evoked potentials in subjects with true premature ejaculation. Andrologia. 1988;20(4):326–30.
Shull GR, Sprenkle DH. Retarded ejaculation reconceptualization and implications for treatment. J Sex Marital Ther. 1980;6(4):234–46.
Semans JH. Premature ejaculation: a new approach. South Med J. 1956;49(4):353–8.
De Amicis LA, Goldberg DC, LoPiccolo J, Friedman J, Davies L. Clinical follow-up of couples treated for sexual dysfunction. Arch Sex Behav. 1985;14(6):467–89.
Busato W, Galindo CC. Topical anaesthetic use for treating premature ejaculation: a double-blind, randomized, placebo-controlled study. BJU Int. 2004;93(7):1018–21.
Henry R, Morales A. Topical lidocaine-prilocaine spray for the treatment of premature ejaculation: a proof of concept study. Int J Impot Res. 2003;15(4):277–81.
Hull EM, Lumley LA, Matuszewich L, Dominguez J, Moses J, Lorrain DS. The roles of nitric oxide in sexual function of male rats. Neuropharmacology. 1994;33(11):1499–504.
McMahon CG, Stuckey BG, Andersen M, Purvis K, Koppiker N, Haughie S, et al. Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation. J Sex Med. 2005;2(3):368–75.
Pryor JL, Althof SE, Steidle C, Rosen RC, Hellstrom WJ, Shabsigh R, et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet. 2006;368(9539):929–37.
Safarinejad MR. Safety and efficacy of dapoxetine in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. Neuropsychopharmacology. 2008;33(6):1259–65.
Waldinger MD, Schweitzer DH. Premature ejaculation and pharmaceutical company-based medicine: the dapoxetine case. J Sex Med. 2008;5(4):966–97.
Kim JJ, Kwak TI, Jeon BG, Cheon J, Moon DG. Effects of glans penis augmentation using hyaluronic acid gel for premature ejaculation. Int J Impot Res. 2004;16(6):547–51.
Lue TF, Basson R, Rosen R, Giuliano F, Khoury S, Montorsi F. Sexual medicine: sexual dysfunctions in men and women. In: McMahon CG, Abdo C, Hull EM, Incrocci L, Levine L, Perelman MA, et al., editors. Plymouth, MA: Health Publications; 2004. p. 409–68.
American Psychiatric Association. Diagnostic criteria from DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000. p. 370, xii.
McMahon CG, Jannini E, Waldinger M, Rowland D. Standard operating procedures in the disorders of orgasm and ejaculation. J Sex Med. 2013;10(1):204–29.
Kinsey AC, Pomeroy WB, Martin CE, New York Academy of Medicine. Sexual behavior in the human male. Philadelphia, PA: WB Saunders Co; 1948. p. 804, xv.
Rowland DL, Keeney C, Slob AK. Sexual response in men with inhibited or retarded ejaculation. Int J Impot Res. 2004;16(3):270–4.
Nathan SG. The epidemiology of the DSM-III psychosexual dysfunctions. J Sex Marital Ther. 1986;12(4):267–81.
Richardson D, Nalabanda A, Goldmeier D. Retarded ejaculation – a review. Int J STD AIDS. 2006;17(3):143–50.
Spector IP, Carey MP. Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav. 1990;19(4):389–408.
Nazareth I, Boynton P, King M. Problems with sexual function in people attending London general practitioners: cross sectional study. BMJ. 2003;327(7412):423.
McCabe MP, Connaughton C. Psychosocial factors associated with male sexual difficulties. J Sex Res. 2014;51(1):31–42.
Mulhall JP, Hsiao W. Men’s sexual health and fertility: a clinician’s guide. Nelson CJ, Brock D, Dean RC, editors. New York, NY: Springer; 2014.
Jannini EA, Simonelli C, Lenzi A. Sexological approach to ejaculatory dysfunction. Int J Androl. 2002;25(6):317–23.
Jannini EA, Simonelli C, Lenzi A. Disorders of ejaculation. J Endocrinol Invest. 2002;25(11):1006–19.
Montorsi F, Adaikan G, Becher E, Giuliano F, Khoury S, Lue TF, et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2010;7(11):3572–88.
Abdel-Hamid IA, el Saleh S. Primary lifelong delayed ejaculation: characteristics and response to bupropion. J Sex Med. 2011;8(6):1772–9.
Perelman MA, Rowland DL. Retarded ejaculation. World J Urol. 2006;24(6):645–52.
Perelman MA. Delayed ejaculation. In: Binik YM, Hall KSK, editors. Principles and practice of sex therapy. 5th ed. New York, NY: The Guilford Press; 2014. p. 138–55.
Waldinger MD. Toward evidence-based genetic research on lifelong premature ejaculation: a critical evaluation of methodology. Korean J Urol. 2011;52(1):1–8.
Gregoire A. ABC of sexual health: assessing and managing male sexual problems. BMJ. 1999;318(7179):315–7.
McMahon CG, Abdo C, Incrocci L, Perelman M, Rowland D, Waldinger M, et al. Disorders of orgasm and ejaculation in men. J Sex Med. 2004;1(1):58–65.
Edwards AE, Husted JR. Penile sensitivity, age, and sexual behavior. J Clin Psychol. 1976;32(3):697–700.
Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. A multinational population survey of intravaginal ejaculation latency time. J Sex Med. 2005;2(4):492–7.
Latini DM, Penson DF, Wallace KL, Lubeck DP, Lue TF. Clinical and psychosocial characteristics of men with erectile dysfunction: baseline data from ExCEED. J Sex Med. 2006;3(6):1059–67.
Gierveld Jde J, van Groenou MB, Hoogendoorn AW, Smit JH. Quality of marriages in later life and emotional and social loneliness. J Gerontol B Psychol Sci Soc Sci. 2009;64(4):497–506.
DasGupta R, Fowler CJ. Sexual and urological dysfunction in multiple sclerosis: better understanding and improved therapies. Curr Opin Neurol. 2002;15(3):271–8.
Enzlin P, Mathieu C, Van Den Bruel A, Vanderschueren D, Demyttenaere K. Prevalence and predictors of sexual dysfunction in patients with type 1 diabetes. Diabetes Care. 2003;26(2):409–14.
Minderhoud JM, Leemhuis JG, Kremer J, Laban E, Smits PM. Sexual disturbances arising from multiple sclerosis. Acta Neurol Scand. 1984;70(4):299–306.
Comarr AE. Sexual function among patients with spinal cord injury. Urol Int. 1970;25(2):134–68.
Xia JD, Han YF, Pan F, Zhou LH, Chen Y, Dai YT. Clinical characteristics and penile afferent neuronal function in patients with primary delayed ejaculation. Andrology. 2013;1(5):787–92.
Fletcher MS, Herzberg Z, Pryor JP. The aetiology and investigation of haemospermia. Br J Urol. 1981;53(6):669–71.
Corona G, Jannini EA, Mannucci E, Fisher AD, Lotti F, Petrone L, et al. Different testosterone levels are associated with ejaculatory dysfunction. J Sex Med. 2008;5(8):1991–8.
Corona G, Jannini EA, Vignozzi L, Rastrelli G, Maggi M. The hormonal control of ejaculation. Nat Rev Urol. 2012;9(9):508–19.
Paduch D, Polzer P, Ni X, Basaria S. Effects of testosterone solution 2 % for the treatment of ejauclatory dysfunction in androgen-deficient men. 20th Annual fall scientific meeting of SMSNA, 20–23 Nov 2014 Program Book. 2014(Abtract 003):53.
Paduch D, Polzer P, Morgentaler A, Althof SE, Ni X, Patel A, et al. Prevalence of ejaculatory dysfunction as a function of testosterone. 20th Annual fall scientific meeting of SMSNA, 20–23 Nov 2014 Program Book. 2014(Abstract 004):52.
Paduch D, Polzer P, Ni X, Basaria S. Testosterone replacement in androgen-deficient men with ejaculatory dysfunction: a randomized controlled trial. J Clin Endocrinol Metab. 2015;100(8):2956–62.
Carani C, Isidori AM, Granata A, Carosa E, Maggi M, Lenzi A, et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab. 2005;90(12):6472–9.
Corona G, Petrone L, Paggi F, Lotti F, Boddi V, Fisher A, et al. Sexual dysfunction in subjects with Klinefelter’s syndrome. Int J Androl. 2010;33(4):574–80.
Fitzgerald P, Dinan TG. Prolactin and dopamine: what is the connection? A review article. J Psychopharmacol. 2008;22(2 Suppl):12–9.
Kruger TH, Hartmann U, Schedlowski M. Prolactinergic and dopaminergic mechanisms underlying sexual arousal and orgasm in humans. World J Urol. 2005;23(2):130–8.
Corona G, Ricca V, Bandini E, Mannucci E, Lotti F, Boddi V, et al. Selective serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Med. 2009;6(5):1259–69.
Kiev A, Feiger A. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients. J Clin Psychiatry. 1997;58(4):146–52.
Keller R, Mongini F. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia. Neurol Sci. 2002;23(5):233–5.
Rowland D, van Diest S, Incrocci L, Slob AK. Psychosexual factors that differentiate men with inhibited ejaculation from men with no dysfunction or another sexual dysfunction. J Sex Med. 2005;2(3):383–9.
Althof SE. Psychological interventions for delayed ejaculation/orgasm. Int J Impot Res. 2012;24(4):131–6.
Fathy A, Shamloul R, AbdelRahim A, Zeidan A, El-Dakhly R, Ghanem H. Experience with Tube (Promedon) malleable penile implant. Urol Int. 2007;79(3):244–7.
Shaeer O. The global online sexuality survey (GOSS): the United States of America in 2011 Chapter III – premature ejaculation among English-speaking male Internet users. J Sex Med. 2013;10(7):1882–8.
Bronner G, Ben-Zion IZ. Unusual masturbatory practice as an etiological factor in the diagnosis and treatment of sexual dysfunction in young men. J Sex Med. 2014;11(7):1798–806.
Perelman M. Idiosyncratic masturbation patterns: a key unexplored variable in the treatment of retarded ejaculation by the practicing urologist. J Urol. 2005;173:340. Abstract 1254.
Sank LI. Traumatic masturbatory syndrome. J Sex Marital Ther. 1998;24(1):37–42.
Rothbart D. He’s just not that into anyone (cover story). New York, 2 Jul 2011, p. 83–8.
Carvalheira A, Traeen B, Stulhofer A. Masturbation and pornography use among coupled heterosexual men with decreased sexual desire: how many roles of masturbation? J Sex Marital Ther. 2014;1–10.
Rowland D, McMahon CG, Abdo C, Chen J, Jannini E, Waldinger MD, et al. Disorders of orgasm and ejaculation in men. J Sex Med. 2010;7(4 Pt 2):1668–86.
Teloken P, Nelson C, Mullhall J. Outcomes with medical treatment of secondary delayed orgasm proposal of a clinical care pathway. J Urol. 2012;187(4 Suppl 1496):606.
Butcher M, Sadowski D, Botchway A, Welliver C, Kohler T. Delayed ejaculation remains a recalcitrant condition: results of a SMSNA survey. 20th Annual fall scientific meeting of SMSNA, 20–23 Nov 2014. Program Book. 2014(Abstract 041):70.
Porst H, Buvat J, Standards Committee of the International Society for Sexual Medicine. Standard practice in sexual medicine. McMahon CG, Waldinger M, Rowland D, Assalian P, Kim YC, Bechara A, et al., editors. Malden, Mass.; Oxford: Blackwell Pub. 2006. p. 188–209.
Aukst-Margetic B, Margetic B. An open-label series using loratadine for the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(5):754–6.
Shin D, Spitz A. The evaluation and treatment of delayed ejaculation. Sex Med Rev. 2014;2(3-4):121–33.
Menendez Abraham E, Moran Viesca P, Velasco Plaza A, Marin B. Modifications of the sexual activity in male rats following administration of antiserotoninergic drugs. Behav Brain Res. 1988;30(3):251–8.
Ashton AK, Hamer R, Rosen RC. Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: a large-scale retrospective study of 596 psychiatric outpatients. J Sex Marital Ther. 1997;23(3):165–75.
Lauerma H. Successful treatment of citalopram-induced anorgasmia by cyproheptadine. Acta Psychiatr Scand. 1996;93(1):69–70.
Steele TE, Howell EF. Cyproheptadine for imipramine-induced anorgasmia. J Clin Psychopharmacol. 1986;6(5):326–7.
Sovner R. Treatment of tricyclic antidepressant-induced orgasmic inhibition with cyproheptadine. J Clin Psychopharmacol. 1984;4(3):169.
McCormick S, Olin J, Brotman AW. Reversal of fluoxetine-induced anorgasmia by cyproheptadine in two patients. J Clin Psychiatry. 1990;51(9):383–4.
DeBattista C, Solvason B, Poirier J, Kendrick E, Loraas E. A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction. J Clin Psychiatry. 2005;66(7):844–8.
Safarinejad MR. Midodrine for the treatment of organic anejaculation but not spinal cord injury: a prospective randomized placebo-controlled double-blind clinical study. Int J Impot Res. 2009;21(4):213–20.
Ferraz MM, Fontanella JC, Damasceno F, Silva de Almeida OM, Ferraz MR. Chronic amantadine treatment enhances the sexual behaviour of male rats. Pharmacol Biochem Behav. 2007;86(4):616–21.
Balon R. Intermittent amantadine for fluoxetine-induced anorgasmia. J Sex Marital Ther. 1996;22(4):290–2.
Wittstock M, Benecke R, Dressler D. Cabergoline can increase penile erections and libido. Neurology. 2002;58(5):831.
Kruger TH, Haake P, Haverkamp J, Kramer M, Exton MS, Saller B, et al. Effects of acute prolactin manipulation on sexual drive and function in males. J Endocrinol. 2003;179(3):357–65.
Veening JG, de Jong TR, Waldinger MD, Korte SM, Olivier B. The role of oxytocin in male and female reproductive behavior. Eur J Pharmacol. 2015;753:209–28.
Labbate LA, Grimes JB, Hines A, Pollack MH. Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction. Ann Clin Psychiatry. 1997;9(4):241–5.
Ashton AK, Rosen RC. Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry. 1998;59(3):112–5.
Landen M, Eriksson E, Agren H, Fahlen T. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol. 1999;19(3):268–71.
Carro-Juareza M, Rodriguez-Manzo G. Yohimbine reverses the exhaustion of the coital reflex in spinal male rats. Behav Brain Res. 2003;141(1):43–50.
Jacobsen FM. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry. 1992;53(4):119–22.
Adeniyi AA, Brindley GS, Pryor JP, Ralph DJ. Yohimbine in the treatment of orgasmic dysfunction. Asian J Androl. 2007;9(3):403–7.
Melnyk J, Marcone M. Aphrodisiacs from plant and animal sources—a review of current scientific literature. Food Res Int. 2011;44:840–50.
Segraves RT. Reversal by bethanechol of imipramine-induced ejaculatory dysfunction. Am J Psychiatry. 1987;144(9):1243–4.
Yager J. Bethanechol chloride can reverse erectile and ejaculatory dysfunction induced by tricyclic antidepressants and mazindol: case report. J Clin Psychiatry. 1986;47(4):210–1.
Stafford SA, Coote JH. Activation of D2-like receptors induces sympathetic climactic-like responses in male and female anaesthetised rats. Br J Pharmacol. 2006;148(4):510–6.
Lu W, Jiang W, Chen J, Yin M, Wang Z, Jiang X. Modulation of brain delivery and copulation by intranasal apomorphine hydrochloride. Int J Pharm. 2008;349(1-2):196–205.
Kendirci M, Hellstrom WJ. Intranasal apomorphine. Nastech Pharmaceutical. Investig Drug J. 2004;7(5):483–8.
Bartlik BD, Kaplan P, Kaplan HS. Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin re-uptake inhibitors. J Sex Marital Ther. 1995;21(4):264–71.
McMahon CG. Management of ejaculatory dysfunction. Intern Med J. 2014;44(2):124–31.
Haberfellner EM. Sexual dysfunction caused by reboxetine. Pharmacopsychiatry. 2002;35(2):77–8.
O'Flynn R, Michael A. Reboxetine-induced spontaneous ejaculation. Br J Psychiatry. 2000;177:567–8.
Sivrioglu EY, Topaloglu VC, Sarandol A, Akkaya C, Eker SS, Kirli S. Reboxetine induced erectile dysfunction and spontaneous ejaculation during defecation and micturition. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(2):548–50.
Taylor MJ. Strategies for managing antidepressant-induced sexual dysfunction: a review. Curr Psychiatry Rep. 2006;8(6):431–6.
Schweitzer I, Maguire K, Ng C. Sexual side-effects of contemporary antidepressants: review. Aust N Z J Psychiatry. 2009;43(9):795–808.
Sonksen J, Ohl DA, Wedemeyer G. Sphincteric events during penile vibratory ejaculation and electroejaculation in men with spinal cord injuries. J Urol. 2001;165(2):426–9.
Nelson CJ, Ahmed A, Valenzuela R, Parker M, Mulhall JP. Assessment of penile vibratory stimulation as a management strategy in men with secondary retarded orgasm. Urology. 2007;69(3):552–5. discussion 5–6.
Previnaire JG, Lecourt G, Soler JM, Denys P. Sexual disorders in men with multiple sclerosis: evaluation and management. Ann Phys Rehabil Med. 2014;57(5):329–36.
Lieblum S, Rosen R. Principles and practice of sex therapy. 2nd ed. New York, NY: Guilford Press; 2000.
Perelman MA. A new combination treatment for premature ejaculation: a sex therapist's perspective. J Sex Med. 2006;3(6):1004–12.
Rust J, Golombok S, Collier J. Marital problems and sexual dysfunction: how are they related? Br J Psychiatry. 1988;152:629–31.
Snyder DK, Berg P. Determinants of sexual dissatisfaction in sexually distressed couples. Arch Sex Behav. 1983;12(3):237–46.
Barnas J, Parker M, Guhring P, Mulhall JP. The utility of tamsulosin in the management of orgasm-associated pain: a pilot analysis. Eur Urol. 2005;47(3):361–5. discussion 5.
Johnson CW, Bingham JB, Goluboff ET, Fisch H. Transurethral resection of the ejaculatory ducts for treating ejaculatory symptoms. BJU Int. 2005;95(1):117–9.
Antolak S, Hough D, Maus T. Chronic pelvic pain syndrome (pudendal neuralgia or category IIIB chronic prostatitis). Rochester, MN: Mayo Clinic; 2002.
Kulik FA, Wilbur R. Case report of painful ejaculation as a side effect of amoxapine. Am J Psychiatry. 1982;139(2):234–5.
Aizenberg D, Zemishlany Z, Hermesh H, Karp L, Weizman A. Painful ejaculation associated with antidepressants in four patients. J Clin Psychiatry. 1991;52(11):461–3.
Hsu JH, Shen WW. Male sexual side effects associated with antidepressants: a descriptive clinical study of 32 patients. Int J Psychiatry Med. 1995;25(2):191–201.
Michael A. Venlafaxine-induced painful ejaculation. Br J Psychiatry. 2000;177:282.
Demyttenaere K, Huygens R. Painful ejaculation and urinary hesitancy in association with antidepressant therapy: relief with tamsulosin. Eur Neuropsychopharmacol. 2002;12(4):337–41.
Roberts RO, Jacobson DJ, Girman CJ, Rhodes T, Lieber MM, Jacobsen SJ. Prevalence of prostatitis-like symptoms in a community based cohort of older men. J Urol. 2002;168(6):2467–71.
Nickel JC, Downey J, Hunter D, Clark J. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol. 2001;165(3):842–5.
Litwin MS, McNaughton-Collins M, Fowler Jr FJ, Nickel JC, Calhoun EA, Pontari MA, et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. 1999;162(2):369–75.
Amarenco G, Ismael SS, Bayle B, Denys P, Kerdraon J. Electrophysiological analysis of pudendal neuropathy following traction. Muscle Nerve. 2001;24(1):116–9.
Nadler RB, Rubenstein JN. Laparoscopic excision of a seminal vesicle for the chronic pelvic pain syndrome. J Urol. 2001;166(6):2293–4.
Anderson RU, Wise D, Sawyer T, Chan CA. Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: improvement after trigger point release and paradoxical relaxation training. J Urol. 2006;176(4 Pt 1):1534–8. discussion 8–9.